Services
Early Commercial Strategy
What are the opportunities for a new drug – which physicians would use it, for which patients, and why? What will the future treatment paradigm and competitive landscape look like? What will it take for a new drug to succeed in that future environment?
Typical projects:
- Preliminary opportunity assessments
- Future market landscaping
- Competitive assessments
- TPP development and testing
Launch Strategy
What will it take to launch a new drug successfully? What is the revenue opportunity and where is it coming from? How should the market be shaped to receive the new product? Typical Projects:
- Physician and account segmentation
- Strategic pillars and message testing
- Demand estimation and forecasting
- Go-to-market strategy
- Medical communications strategy
Commercial Analytics & Growth Strategy
Where are the opportunities to grow a marketed drug? How can they be realized?
Typical Projects:
- Strategic objectives and KPI tracking
- Marketing message testing
- Competitor defense strategy
- Lifecycle strategy development
Market Access
What is the value of the new drug to patients, payers and physicians? How should this value be reflected in pricing? What is the US and global market access strategy?
Typical Projects
- Payer value story and message-testing
- US launch pricing and contracting strategy
- EU, Asia and Latin American pricing
- Life-cycle pricing and contracting strategy
- Competitive simulation and scenario planning
- ASP-based drug financial modelling
BD&L Strategy
Which assets should pharma developers acquire and how? Who should biotech innovators partner with and how? How much are they worth? What assets and companies should investors invest in?
Typical Projects:
- Commercial and scientific due diligence
- BD scans to inform search & eval
- Competitive market landscaping
- Technology assessments
- Alliance partner profiling & matching
Portfolio & Development Strategy
Which diseases should be pursued, with which technologies, and how? What capabilities are needed? What gaps / risks exist and how should they be addressed? What is the optimal plan for developing clinical-stage assets, optimizing for revenue, speed, and/or risk? Given limited resources, how can the portfolio be optimized to meet goals?
Typical Projects
- Disease area strategy
- Portfolio prioritization and co-positioning
- Indication / technology prioritization
- Development planning
- Lifecycle management planning
The Vital Way
Our Guiding Beats
Critical Thinking
Challenging conventional wisdom and following the data wherever it leads.
Adaptive
Evolving with the dynamic healthcare market.
Collaborative
Close teamwork with leadership teams to deliver outcomes & earn long-term trust.
Curious
Passionate about healthcare and getting to the right answers.
Strategic
Making actionable recommendations to win over time, not just solving the immediate problem in front of you.
Excellence
An uncompromising commitment to excellence and doing the hard work required to get it right.
Unlocking What’s Possible
From Breakthroughs to Impact
We turn scientific potential into real-world progress that improves lives.
Bridging Science and Strategy
We connect discovery with execution — helping biotech teams move from concept to clinic.
Accelerating Innovation
We empower organizations to move faster and smarter through every stage.
Empowering Growth
From funding to full-scale commercialization, we help you realize what’s next.
Building the Future of Biotech
Together, we unlock new frontiers in science, technology, and human health.
Where Insight Meets Action
Because every great idea deserves the chance to change the world.